The article discusses nighttime doping tests conducted during the Tour de France, which have caused controversy among cyclists. The International Testing Agency (ITA) carried out these tests on a rest day, targeting riders still in the race, as part of efforts to detect substances like growth hormones and testosterone that break down quickly. While some athletes, including Jonas Vingegaard, were awakened during these tests, there was no confirmed doping violation this year. Experts like Ernst König from Swiss Sports Integrity argue that nighttime testing is necessary to catch substances that become undetectable by morning, though they emphasize the need for balance to avoid disrupting athletes’ performance. No doping cases were reported at the 2026 Tour.
Bias read (Center): The article presents both sides of the debate—highlighting concerns raised by cyclists and the rationale provided by experts. It does not take a clear ideological stance but rather reports on the controversy and expert opinions without overtly favoring either side. The framing remains balanced, with






